SCHEMBL770550

SCHEMBL770550

CC1CC(C)CN(C(=O)CCNC(=O)N2CCC3CCCCC3C2)C1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HSD11B1 P28845 1/20 0.39
KMT2A Q03164 2/20 0.38
MEN1 O00255 1/20 0.37
POLB P06746 1/20 0.37
MAPT P10636 1/20 0.37
LMNA P02545 3/20 0.37
NPC1 O15118 1/20 0.37
ALDH1A1 P00352 2/20 0.37
CHRM1 P11229 1/20 0.36
USP2 O75604 1/20 0.34
TSHR P16473 1/20 0.34
GNAI3 P08754 2/20 0.33
GNAO1 P09471 2/20 0.33
GNAI1 P63096 2/20 0.33
HPGD P15428 1/20 0.33
SMN1; SMN2 Q16637 1/20 0.33
ITGB3 P05106 1/20 0.33
ITGA2B P08514 1/20 0.33
F2R P25116 1/20 0.33
KDM4E B2RXH2 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL771470 0.93 NPC1 (0.41) HSD11B1KMT2AMEN1POLBMAPT
SCHEMBL770235 0.90 NPC1 (0.49) HSD11B1KMT2AMEN1POLBMAPT
SCHEMBL770232 0.89 ALDH1A1 (0.51) KMT2AMEN1POLBMAPTLMNA
SCHEMBL770442 0.88 HSD11B1 (0.42) HSD11B1KMT2ALMNACHRM1GNAI3
SCHEMBL770609 0.85 KMT2A (0.47) HSD11B1KMT2AMEN1POLBMAPT
SCHEMBL770876 0.83 NPC1 (0.53) HSD11B1KMT2AMEN1POLBMAPT
SCHEMBL771284 0.83 MEN1 (0.51) HSD11B1KMT2AMEN1POLBMAPT
SCHEMBL770292 0.83 HSD11B1 (0.46) HSD11B1KMT2AMEN1POLBMAPT
SCHEMBL771047 0.82 NPC1 (0.54) HSD11B1KMT2AMEN1POLBMAPT
SCHEMBL769690 0.82 KMT2A (0.55) KMT2AMEN1POLBMAPTLMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20130303522-A1 INHIBITOR COMPOUNDS OF 11-BETA-HYDROXYSTEROID DEHYDROGENASE TYPE 1 LABORATORIOS SALVAT, S.A. (ES) 2013-11-14 US disclosed
US-20120071466-A1 INHIBITOR COMPOUNDS OF 11-BETA-HYDROXYSTEROID DEHYDROGENASE TYPE 1 LABORATORIOS SALVAT, S.A. (ES) 2012-03-22 US disclosed
US-20120071466-A1 INHIBITOR COMPOUNDS OF 11-BETA-HYDROXYSTEROID DEHYDROGENASE TYPE 1 LABORATORIOS SALVAT, S.A. (ES) 2012-03-22 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130303522-A1 INHIBITOR COMPOUNDS OF 11-BETA-HYDROXYSTEROID DEHYDROGENASE TYPE 1 HSD11B1, HSD17B1, HSD11B2 HSD11B1 1/4885KMT2A 3868/4885MEN1 827/4885
US-20120071466-A1 INHIBITOR COMPOUNDS OF 11-BETA-HYDROXYSTEROID DEHYDROGENASE TYPE 1 HSD11B1, HSD17B1, HSD11B2 HSD11B1 1/4885KMT2A 3893/4885MEN1 823/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.